lamivudine has been researched along with Sexually Transmitted Disease, Viral in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benech, H; Bourry, O; Brochard, P; Calvo, J; Dereudre-Bosquet, N; Kazanji, M; Le Grand, R; Makuwa, M; Martinon, F; Souquiere, S | 1 |
| Chayama, K; Takahashi, S | 1 |
| Angel, JB; Cameron, DW; Garber, GE; Hawley-Foss, N; Houston, S; Kravcik, S; Sutherland, D; Victor, G | 1 |
| Bamberger, JD; Chambers, D; Chesney, M; Coates, TJ; Franses, K; Kahn, JO; Katz, MH; Martin, JN; Roland, ME | 1 |
| Matthews, GV; Nelson, MR | 1 |
| Alba, L; Antinori, A; Grisetti, S; Liuzzi, G; Sette, P; Zaccarelli, M | 1 |
2 review(s) available for lamivudine and Sexually Transmitted Disease, Viral
| Article | Year |
|---|---|
[Attention-getting sexually transmitted diseases: Hepatitis B].
Topics: Adenine; Adenosine; Antiviral Agents; Comorbidity; Drug Therapy, Combination; Genotype; Guanine; Guanosine; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Organophosphonates; Reverse Transcriptase Inhibitors; Sexually Transmitted Diseases, Viral | 2007 |
The management of chronic hepatitis B infection.
Topics: Antiviral Agents; DNA, Viral; Hepatitis B Antigens; Hepatitis B virus; Hepatitis B, Chronic; HIV Infections; Humans; Interferon-alpha; Lamivudine; Reverse Transcriptase Inhibitors; Sexually Transmitted Diseases, Viral; Treatment Outcome | 2001 |
4 other study(ies) available for lamivudine and Sexually Transmitted Disease, Viral
| Article | Year |
|---|---|
Prevention of vaginal simian immunodeficiency virus transmission in macaques by postexposure prophylaxis with zidovudine, lamivudine and indinavir.
Topics: Administration, Oral; Animals; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Indinavir; Injections, Subcutaneous; Lamivudine; Macaca fascicularis; Sexually Transmitted Diseases, Viral; Simian Acquired Immunodeficiency Syndrome; Vagina; Viral Load; Viremia; Zidovudine | 2009 |
Effect of antiretroviral therapy and viral load on the perceived risk of HIV transmission and the need for safer sexual practices.
Topics: Anti-HIV Agents; Attitude to Health; CD4 Lymphocyte Count; Female; HIV Infections; Humans; Lamivudine; Male; Protease Inhibitors; Reverse Transcriptase Inhibitors; Risk Factors; Sexual Behavior; Sexual Partners; Sexually Transmitted Diseases, Viral; Surveys and Questionnaires; Viral Load; Zidovudine | 1998 |
Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP Study.
Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Contact Tracing; Counseling; Didanosine; Female; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Nelfinavir; Patient Compliance; Reverse Transcriptase Inhibitors; Risk Factors; Risk-Taking; Sexually Transmitted Diseases, Viral; Substance Abuse, Intravenous; Time Factors; Zidovudine | 2001 |
Acute hepatitis B by sexual transmission after interruption of lamivudine-containing antiretroviral regimen.
Topics: Acute Disease; Adult; Anti-HIV Agents; Coitus; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepatitis B; HIV Infections; Humans; Lamivudine; Male; Pregnancy; Reverse Transcriptase Inhibitors; Sexually Transmitted Diseases, Viral | 2001 |